Nov 30, 2016 11:05 am UTC| Business
- Janssen initiates dosing of patients in OMEGA-1: Phase 2b study evaluating six- and eight-week treatment durations with JNJ-4178, a 3DAA combination of odalasvir, simeprevir, and AL-335, for the treatment of chronic HCV...
Mats Wahlström Joins Surefire Medical Board of Directors
Nov 30, 2016 11:00 am UTC| Business
WESTMINSTER, Colo., Nov. 30, 2016 -- Surefire Medical, Inc. today announced that Mats Wahlström is joining the company’s Board of Directors and will serve as chairman. Wahlström has more than 30 years of experience in...
Incap India wins the prestigious exports award of STPI
Nov 30, 2016 10:45 am UTC| Business
HELSINKI, Finland, Nov. 30, 2016 -- INCAP INDIA WINS THE PRESTIGIOUS EXPORTS AWARD OF STPIIncap Contract Manufacturing Services Pvt Ltd has been honored with the Prestigious Exports Award for the year 2015-2016....
Nov 30, 2016 10:30 am UTC| Business
SEATTLE, Nov. 30, 2016 -- Nohla Therapeutics Inc. (Nohla), a leading developer of universal donor cellular therapies for the treatment of patients with life threatening hematological disorders, announced today the...
SurePeople Expands Cloud-Based Talent Solutions to Latin America
Nov 30, 2016 10:05 am UTC| Business
CHICAGO, Nov. 30, 2016 -- SurePeople, a global technology innovator providing cloud-based talent solutions driven by qualitative and quantitative data, and Zelf Experience, a talent management and human resources...
Bell Integrator Among 500 Largest Software Companies
Nov 30, 2016 09:57 am UTC| Business
SAN JOSE, Calif., Nov. 30, 2016 -- Bell Integrator, a global consulting, technology services and outsourcing company, has been included in the Software 500 ranking of the world’s largest software and service providers...
Nov 30, 2016 09:18 am UTC| Business
Marseille, France, Nov. 30, 2016 -- FIRST CLINICAL DATA FOR MONALIZUMAB as a single agent in cancer patients show favorable SAFETY PROFILE Data from the dose-ranging part of a Phase I/II trial of monalizumab in...